1. CMU Intellectual Repository

Browsing by Author Tim R. Cressey

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 40 to 59 of 108 < previous   next >
Issue DateTitleAuthor(s)
1-Feb-2019Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral ProphylaxisSuvaporn Anugulruengkitt; Tim R. Cressey; Piyarat Suntarattiwong; Pradthana Ounchanum; Ussanee Srirompotong; Watsamon Jantarabenjakul; Jiratchaya Sophonphan; Yardpiroon Tawon; Sunti Punnahitanon; Chitsanu Pancharoen; Kulkanya Chokephaibulkit; Thanyawee Puthanakit
1-Oct-2012Nevirapine exposure with WHO pediatric weight band dosing: Enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experienceMina Nikanjam; Desiré Kabamba; Tim R. Cressey; David Burger; Francesca T. Aweek; Edward P. Acosta; Stephen A. Spector; Edmund V. Capparelli
1-Jan-2015New-onset diabetes and antiretroviral treatments in HIV-infected adults in ThailandPrakit Riyaten; Nicolas Salvadori; Patrinee Traisathit; Nicole Ngo-Giang-Huong; Tim R. Cressey; Prattana Leenasirimakul; Malee Techapornroong; Chureeratana Bowonwatanuwong; Pacharee Kantipong; Ampaipith Nilmanat; Naruepon Yutthakasemsunt; Apichat Chutanunta; Suchart Thongpaen; Virat Klinbuayaem; Luc Decker; Sophie Le Coeur; Marc Lallemant; Jacqueline Capeau; Jean Yves Mary; Gonzague Jourdain
1-Dec-2021ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosingCecilia L. Moore; Anna Turkova; Hilda Mujuru; Adeodata Kekitiinwa; Abbas Lugemwa; Cissy M. Kityo; Linda N. Barlow-Mosha; Tim R. Cressey; Avy Violari; Ebrahim Variava; Mark F. Cotton; Moherndran Archary; Alexandra Compagnucci; Thanyawee Puthanakit; Osee Behuhuma; Yacine Saϊdi; James Hakim; Pauline Amuge; Lorna Atwine; Victor Musiime; David M. Burger; Clare Shakeshaft; Carlo Giaquinto; Pablo Rojo; Diana M. Gibb; Deborah Ford; Shabinah Ali; Abdel Babiker; Chiara Borg; Anne Marie Borges Da Silva; Joanna Calvert; Joshua Gasa; Nasir Jamil; Sarah Lensen; Emma Little; Fatima Mohamed; Samuel Montero; Cecilia L. Moore; Rachel Oguntimehin; Anna Parker; Reena Patel; Tasmin Phillips; Tatiana Sarfati; Karen Scott; Moira Spyer; Margaret Thomason; Rebecca Turner; Nadine Van Looy; Ellen White; Kaya Widuch; Helen Wilkes; Ben Wynne; Tiziana Grossele; Daniel Gomez-Pena; Davide Bilardi; Giulio Vecchia; Yacine Saidi; Yoann Riault; Alexandra Coelho; Laura Picault; Christelle Kouakam; Suwalai Chalermpantmetagul; Dujrudee Chinwong; Gonzague Jourdain; Rukchanok Peongjakta; Pra ornsuda Sukrakanchana; Wasna Sirirungsi; Janet Seeley; Sarah Bernays; Magda Conway; Nigel Klein; Eleni Nastouli; Anita De Rossi; Maria Angeles Munoz Fernandez; David Burger; Pauline Bollen; Angela Colbers; Hylke Waalewijn; Elizabeth Kaudha; Annet Nanduudu; Emmanuel Mujyambere; Paul Ocitti Labeja; Charity Nankunda; Juliet Ategeka; Peter Erim; Collin Makanga; Esther Nambi; Edridah Keminyeto; Deogratiuos Tukwasibwe; Shafic Makumbi; Emily Ninsiima; Mercy Tukamushaba; Rogers Ankunda; Ian Natuhurira; Miriam Kasozi; Baker Rubinga; Adeodata R. Kekitiinwa; Dickson Bbuye; Justine Nalubwama; Winnie Akobye
1-Dec-2012Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavirKulkanya Chokephaibulkit; Maneeratn Nuntarukchaikul; Wanatpreeya Phongsamart; Orasri Wittawatmongkol; Keswadee Lapphra; Nirun Vanprapar; Tim R. Cressey
1-Jan-2022One dose does not fit all: revising the WHO paediatric dosing tool to include the non-linear effect of body size and maturationPaolo Denti; Roeland E. Wasmann; Jose Francis; Helen McIlleron; Nandita Sugandhi; Tim R. Cressey; Mark Mirochnick; Edmund V. Capparelli; Martina Penazzato
1-Jan-2017Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patientsNaïm Bouazza; Tim R. Cressey; Frantz Foissac; Andrzej Bienczak; Paolo Denti; Helen McIlleron; David Burger; Martina Penazzato; Marc Lallemant; Edmund V. Capparelli; Jean Marc Treluyer; Saïk Urien
15-Aug-2018Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIVDeborah Ford; Rebecca Turner; Anna Turkova; Martina Penazzato; Victor Musiime; Mutsa Bwakura-Dangarembizi; Avy Violari; Chishala Chabala; Thanyawee Puthanakit; Tavitiya Sudjaritruk; Tim R. Cressey; Marc Lallemant; Diana M. Gibb
1-Aug-2019Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIVHylke Waalewijn; Anna Turkova; Natella Rakhmanina; Tim R. Cressey; Martina Penazzato; Angela Colbers; David M. Burger
1-Jan-2020Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons from HIV: A Consensus StatementAhizechukwu C. Eke; Adeniyi Olagunju; Jeremiah Momper; Martina Penazzato; Elaine J. Abrams; Brookie M. Best; Edmund V. Capparelli; Adrie Bekker; Yodit Belew; Jennifer J. Kiser; Kimberly Struble; Graham Taylor; Catriona Waitt; Mark Mirochnick; Tim R. Cressey; Angela Colbers; Elaine Abrams; Grace Aldrovandi; Brookie Best; Roberta Black; Marta Boffito; Andrew Bremer; Kristina Brooks; David Burger; Edmund Capparelli; Nahida Chakhtoura; Lamek Chinula; Kulkanya Chokephaibulkit; Diana Clarke; Angela Colbers; Richard Court; Tim R. Cressey; Ahizechukwu Eke; Myriam El Gaaloul; Terrence Fenton; Rohan Hazra; Patrick Jean-Philippe; John Kinuthia; Jennifer Kiser; Regis Kreitchman; Mohammed Lamorde; Linda Lewis; Maggie Little
1-Jul-2020Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before DeliveryMarc Lallemant; Billy Amzal; Patumrat Sripan; Saïk Urien; Tim R. Cressey; Nicole Ngo-Giang-Huong; Virat Klinbuayaem; Boonsong Rawangban; Prapan Sabsanong; Thitiporn Siriwachirachai; Tapnarong Jarupanich; Prateep Kanjanavikai; Phaiboon Wanasiri; Suporn Koetsawang; Gonzague Jourdain; Sophie Le Coeur
1-Dec-2012Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adultsChonlaphat Sukasem; Tim R. Cressey; Pattamawan Prapaithong; Yardpiroon Tawon; Ekawat Pasomsub; Chutatip Srichunrusami; Thawinee Jantararoungtong; Marc Lallement; Wasun Chantratita
12-Jan-2010Pharmacogenetics and the prevention of mother-to-child transmission of HIVTim R. Cressey; Marc Lallemant
9-Oct-2015Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adultsSiwalee Rattanapunya; Tim R. Cressey; Ronnatrai Rueangweerayut; Yardpiroon Tawon; Panida Kongjam; Kesara Na-Bangchang
1-Dec-2015Pharmacokinetic interactions between quinine and lopinavir/ritonavir in healthy Thai adultsSiwalee Rattanapunya; Tim R. Cressey; Ronnatrai Rueangweerayut; Yardpiroon Tawon; Panida Kongjam; Kesara Na-Bangchang
1-Oct-2012Pharmacokinetic optimization of antiretroviral therapy in pregnancyKajal Buckoreelall; Tim R. Cressey; Jennifer R. King
19-Dec-2011Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenKulkanya Chokephaibulkit; Tim R. Cressey; Edmund Capparelli; Virat Sirisanthana; Petronella Muresan; Suchat Hongsiriwon; Chaiwat Ngampiyaskul; Chanin Limwongse; Orasri Wittawatmongkol; Linda Aurpibul; Bill Kabat; Mari Pat Toye; Mary Elizabeth Smith; Achara Eksaengsri; Kenneth McIntosh; Ram Yogev
1-Mar-2022Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE StudyAdrie Bekker; Helena Rabie; Nicolas Salvadori; Samantha Du Toit; Kanchana Than-In-At; Marisa Groenewald; Isabelle Andrieux-Meyer; Mukesh Kumar; Ratchada Cressey; James Nielsen; Edmund Capparelli; Marc Lallemant; Mark F. Cotton; Tim R. Cressey
10-Sep-2010Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancyTim R. Cressey; Gonzague Jourdain; Boonsong Rawangban; Supang Varadisai; Rucha Kongpanichkul; Prapan Sabsanong; Prapap Yuthavisuthi; Somnuk Chirayus; Nicole Ngo-Giang-Huong; Nipunporn Voramongkol; Somsak Pattarakulwanich; Marc Lallemant
1-May-2013Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancyRegis Kreitchmann; Brookie M. Best; Jiajia Wang; Alice Stek; Edmund Caparelli; D. Heather Watts; Elizabeth Smith; David E. Shapiro; Steve Rossi; Sandra K. Burchett; Elizabeth Hawkins; Mark Byroads; Tim R. Cressey; Mark Mirochnick
Showing results 40 to 59 of 108 < previous   next >